Blaine Doyle Email

CEO . GlowDx

Current Roles

Employees:
29
Revenue:
$4.5M
About
GlowDx is developing the Worlds First True Point-of-Care (POC) Diagnostics Platform, aimed at tackling Infectious Disease in Emerging Economies. Our first test detects mosquito-bourne infections (Dengue Fever, Chikungunya & Zika Virus), while our AI utilizes machine learning to model & predict future outbreaks.
GlowDx Address
IndieBio EU
Kilkenny, null
GlowDx Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.